# Tandem Diabetes Care Sets 2026 Sales Outlook at $1.065 Billion to $1.085 Billion

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/51022
Published: 2026-11-07T19:24:25.000Z
Updated: 2026-11-07T19:24:25.000Z
Section: Business

> The company also projected gross margins of 56% to 57% and adjusted EBITDA margins of 5% to 6%.

Tandem Diabetes Care management expects worldwide sales of $1.065 billion to $1.085 billion in 2026, while CEO John Sheridan is preparing to retire at the end of 2026.

For 2026, Tandem projects an adjusted EBITDA margin of 5% to 6%, alongside a 56% to 57% gross margin. Management described mid- to high-single-digit revenue growth in 2027 as a fair starting point.

The leadership transition also includes Jeannette Bankes.